|
Volumn 75, Issue 3, 2000, Pages 278-284
|
Management of difficult to control hypertension
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMLODIPINE PLUS BENAZEPRIL;
ANGIOTENSIN RECEPTOR ANTAGONIST;
ANTIHYPERTENSIVE AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BUMETANIDE;
CALCIUM CHANNEL BLOCKING AGENT;
DILTIAZEM;
DILTIAZEM PLUS ENALAPRIL MALEATE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
ENALAPRIL;
ENALAPRIL MALEATE PLUS FELODIPINE;
FELODIPINE;
FUROSEMIDE;
HYDRALAZINE;
HYDROCHLOROTHIAZIDE;
HYDROCHLOROTHIAZIDE PLUS METHYLDOPA;
METHYLDOPA;
METOLAZONE;
NONSTEROID ANTIINFLAMMATORY AGENT;
OMAPATRILAT;
RESERPINE;
TRANDOLAPRIL PLUS VERAPAMIL;
UNCLASSIFIED DRUG;
ALCOHOL CONSUMPTION;
ANTIHYPERTENSIVE THERAPY;
BLOOD PRESSURE REGULATION;
CAUSE OF DEATH;
DIURETIC THERAPY;
DRUG ANTAGONISM;
DRUG MIXTURE;
DRUG POTENTIATION;
HEALTH BEHAVIOR;
HEALTH SURVEY;
HEART DISEASE;
HUMAN;
HYPERTENSION;
PATHOPHYSIOLOGY;
PATIENT COMPLIANCE;
PRACTICE GUIDELINE;
RENOVASCULAR DISEASE;
REVIEW;
RISK FACTOR;
SCREENING;
SODIUM RESTRICTION;
STROKE;
TREATMENT PLANNING;
WATER DEPRIVATION;
|
EID: 0034102082
PISSN: 00256196
EISSN: None
Source Type: Journal
DOI: 10.1016/s0025-6196(11)65033-7 Document Type: Review |
Times cited : (41)
|
References (18)
|